N
Google TrendLAMINE YAMAL (2000+) — "You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:lamine yamal2000+abdulrahman alfozan500+pope francis500+olise500+delaware vs middle tennessee prediction500+bayern de múnich200+gme1000+flashscore200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Prasugrel versus Clopidog" (30 stories)

Top Headline Story

Meta-analysis: Prasugrel the Best P2Y12 Inhibitor After PCI?
Lead StoryTCTMD.comgeneral
Jun 5

Meta-analysis: Prasugrel the Best P2Y12 Inhibitor After PCI?

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOWFRTRVdqWFh5dG9ZWXRSeVZwLW43VkRldDJYbnFxOUV3S3dqUFpPZlJyVWMwWjdFME1IQmxuX1BnOFc3YUF4bHQ0ODUzLUdheV9XS3RsMW51dElBV3U4bTUwc1NXU0o4V1VIRXVIRDBBRjkwQXcxNkR0VG5kWmhQWHY2QWMwUHZU?oc=5" target="_blank">Meta-analysis: Prasugrel the Best P2Y12 Inhibitor After PCI?</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+19m ago

lamine yamal

"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words

Filter stories
500+29m ago

abdulrahman alfozan

OpenAI engineer arrested in bugging of executive conference room

Filter stories
500+29m ago

pope francis

The Myth of St. Francis

Filter stories
500+29m ago

olise

Bayern’s Michael Olise sent off for 2 yellow cards within seconds in Champions League

Filter stories

Search Results for "Prasugrel versus Clopidog"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Prasugrel after PCI outperforms other common antiplatelet drugs
Cardiovascular Businessgeneral

Prasugrel after PCI outperforms other common antiplatelet drugs

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQQU1YS3Z6bmhhTXZBaEhadFJiQUFGN0FxM19mcnl6SDhLWlpIdkVYdWVKZkRNWDZMck1ualRCX3RQSC1LTmdZSWxzelAxbG1GRHRyVGZaOUhlamZDNFFCMlVOSm9jOGNkcXJUX204T1AtVjFCUkR4cDlNR1FZMm5LVGJCRVVrTHR5WFY0Ukd4eWJ5Zm1BVFhRYmVhOFZuMzBLazg0NmJFdjQtQWtPTHdEc250djRiR1ctSmF4MXFhNkU1QXo0bHNEUV9tYVRzY00tMDZSNEFCMA?oc=5" target="_blank">Prasugrel after PCI outperforms other common antiplatelet drugs</a>  <font color="#6f6f6f">Cardiovascular Business</font>

Read Full StoryMore like this
Prasugrel Outshines Rival Drugs After Invasive Coronary Care
Medscapegeneral

Prasugrel Outshines Rival Drugs After Invasive Coronary Care

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPWGpuYmlXY2NySktDZG5vNGZwLVdJbFgwRFlFOUhPLXBCSGRlTVdFNDNXV1pEVlM4dE9iTHVISi1VSjJtczlySm4wOXBqYkRlN1FvOXhSMFJaemxiMkJKaktJVjU4NWgyX1l0Yl9CZDM0dUN5TTRvLWdFVDBXYTJVZlFiSTgxOUJrR2l1cUVEX3lEZTNUTks4UG52RUlpMUFEUHl0aGhsQnVMVE5fM1Fj?oc=5" target="_blank">Prasugrel Outshines Rival Drugs After Invasive Coronary Care</a>  <font color="#6f6f6f">Medscape</font>

Read Full StoryMore like this
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
NEJMgeneral

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5BN1JNS2FSZ2FZUXpWNkUya0ZYOXZGUkJQMThYQnZDNHF0Tm1uQ2tTWDl5TTdOblY2ZG45SURkSmRhOERSU2tBWXVoOS0weWIxZVY2eGJzcWpCWXBERTZHbw?oc=5" target="_blank">Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial
The Lancetgeneral

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPbDI0aER6Qk1adEFsZFFtZmhnVk1sVTA0RlZzTk5hMDZNUmZwZElycXpJVVJYdXR0YXNRc3cyQzJFSWpKb1NOZUY1SWhNTnpIQ2U0TW5DT2tXU1liVlNoVTliZ0dySGU0ampieWg4Z2hkOUNBUG02c0kyNkQtNWZaeGtIc2FNTVQ2MWJF?oc=5" target="_blank">Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Prasugrel Shows Best Efficacy-Safety Balance After PCI Compared to Ticagrelor and Clopidogrel: JAMA
Medical Dialoguesgeneral

Prasugrel Shows Best Efficacy-Safety Balance After PCI Compared to Ticagrelor and Clopidogrel: JAMA

<a href="https://news.google.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?oc=5" target="_blank">Prasugrel Shows Best Efficacy-Safety Balance After PCI Compared to Ticagrelor and Clopidogrel: JAMA</a>  <font color="#6f6f6f">Medical Dialogues</font>

Read Full StoryMore like this
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
NEJMgeneral

Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE83dTAwSHNLVkd0WUl4cVJQS1pmZTAtWlBXc3ZvQjJmblg5UFM0MjBoT0NqRk9nSWFyaXRvSkZnaHQ0ZWNMREN2a0FaZmhYLTJGWWRqTjNodzduOVM3V2VDZg?oc=5" target="_blank">Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis | Scientific Reports
Naturegeneral

Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1XSmhQYVJJdnRJRGFNVkUteWdHQ3J1QlNGa0Y0R0xHUXJZN1FUS0ZtTVB0WW5BWkUwVDRNMnRKOWZGbUIyUEFibzdlZHRnS0xaM3FnaEZaRVc4M3NVX2sw?oc=5" target="_blank">Efficacy and safety of newer P2Y12 inhibitors for acute coronary syndrome: a network meta-analysis | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromes∗:
JACC Journalsgeneral

Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromes∗:

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE44ZVYwVHJUUXJnOXBGSjVMVUJZbmwtc2o5SWdfV2JaMFpXb0FZWVNXNlBPbjFjZjRkWng1aDBrZFVIRWYyVDNLN0lHTFJ4YXVGU0RacjctdWNVMUFvaXRzUA?oc=5" target="_blank">Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromes∗:</a>  <font color="#6f6f6f">JACC Journals</font>

Read Full StoryMore like this
Efficacy and Safety of Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
Cureusworld

Efficacy and Safety of Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

<a href="https://news.google.com/rss/articles/CBMivwJBVV95cUxPWTZuQUhvT2FVaFZtbUUtMDN1R2Y2a1lfdUVJWFZreVhOODE4M0FRV2hXaC1WQVJfWm5PLXU4QXhmNTU0ak9pbnhCY3dOakFhSUh1YVJiaWY0X1NIcnRKWko2Ukw2T3pDNnRRSi1paDR4cW9yMHoxb3ZSWGhiRW1naElUNjNvRFQ4WVRvNE9ON0xsUnMzZC1iN3lfRTMxYTBDZ0dObjBERjk2Tk1pa0cxSVZ3NFNQZkNVb2U0NUlaMzQ0ZWR0S09GVVNZQkE5OHctN05CT3NNUTB4dFZNOXpZdnpOVHFPcXRrNVRPMnRPLUVfRlRPQmFEb3VPNUhWWUFHSU9idmh6OHl6V1lraUJRR1o5Y0dJMllxM29OYU9rbGt3NkVrbHVDaUNXR212cW1saUpNTTdDMlZpTHFCa2c0?oc=5" target="_blank">Efficacy and Safety of Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
Comparative Efficacy of Clopidogrel vs Prasugrel in Noncardioembolic Ischemic Stroke
Neurology Advisorgeneral

Comparative Efficacy of Clopidogrel vs Prasugrel in Noncardioembolic Ischemic Stroke

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZDhEQWdQVzBEQUx4b2M2MTVjTUtVZ21vSGQ4Y1ZNaUJVOV9idjBGRmhndmJPdVBlYmZTQWl0cWJiN2toRXhYTkZtRGp3UGZENHpGTXg2WFpfSGVVRlhyWFVxZWhsRUxYYXRSekRuNDloLUt6bFVpbTFidFM3bnpMRzNWWThnWUFQNGU3bU1INUw5dHd2WGNVd0o3MDFhTURwQ0FVbXFRYUE2alVIT2w3U3FYYVF4LTkxSi1pUDRZa0Q?oc=5" target="_blank">Comparative Efficacy of Clopidogrel vs Prasugrel in Noncardioembolic Ischemic Stroke</a>  <font color="#6f6f6f">Neurology Advisor</font>

Read Full StoryMore like this
European NSTEMI guidelines—return of clopidogrel? | European Journal of Clinical Pharmacology
Springer Nature Linkworld

European NSTEMI guidelines—return of clopidogrel? | European Journal of Clinical Pharmacology

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1hMkhSblo5eU9DQ2xMNV9uWkJVTV9fMTd6T1VxYWJ1Q1A3YWNPOUpmTUZoYlhfeEs3M092T2E1UTRQdzNqa3lid2hRSkNybTJPLWkza2JaalJMWkhkdWJKTVZPdEo1ZjM1bE16Yg?oc=5" target="_blank">European NSTEMI guidelines—return of clopidogrel? | European Journal of Clinical Pharmacology</a>  <font color="#6f6f6f">Springer Nature Link</font>

Read Full StoryMore like this
Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI
JACC Journalsgeneral

Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9hc0hYWmNLZVpwQ2pkM25NZE1tQjcybXdtVXo5aGg5ajRMemswLW8wUjZjT050YUg0cUczQ2hydnlDVVY0Z25qclBKRVJGZE5FVkI4U0hNczgzVFdDdWZaag?oc=5" target="_blank">Shedding Light on Long-Term Effects of Early Antiplatelet Strategies After Fibrinolytic Treatment in STEMI</a>  <font color="#6f6f6f">JACC Journals</font>

Read Full StoryMore like this
Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD
TCTMD.comgeneral

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxNZURrS2p4Z1FMaktuTnppYzFCQmRONy1Jc3p2YVNLWnlhbFdFNWhpVUZSSjQta3Q5SW5wYVFobnFYbHdmTFJXVGdTZ0NsczJCdmpvMFJpZWlaUWZhWnJhajhfOXBITUhLUGxwSlF5TXZWTnVEMm84S2VQZEwySElHTjFhdG1halZSTjhFYVNJb3RLRG9iSGFlanMxU1NObjQ?oc=5" target="_blank">Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
NEJMgeneral

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5haFVBMEdEQ3VlNC1IcWtrRlhoYWFjamZnSXA0RW5Cd0tPejljcEMwaGJIaVBMZ2NYb29jR0hxcGRWYTIwbTgtQTVERkdvQUNfdjE0OThWd2hEYmlqMWRtbw?oc=5" target="_blank">Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
The Lancetgeneral

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxONzdzTFhzMktuZzA4Y1N6a1hzLTlSQVhjUmFwZzBlbW5MdFpBekV1NHM0QUQydFlla0dhOWljOHhTR1NDaTltUFNYRWlueWNNSDQ4eUs2NkJvTXFGWWR4TG8tSkRHRzRueEliTmFaSnNtZnZfNmFnaDRVUlJlZ3FXcDBfNVVyeEd5TE93?oc=5" target="_blank">Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
NEJMgeneral

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBXam1kWnhkQm5QQTdXX0lrMVBfV1FabHpFalQ2aU14NVJKSDZ2OHg0VEJtOEFqM1k3bHNZa0drWUx4cTlaT3BpZ2RDS0dOZ0hIMlFQVWtyZUJ3dkp1WFFmaQ?oc=5" target="_blank">Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
NEJMgeneral

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1mRGNCSXhETnR6Y1BFck9wbmxFLU9JYWZrUjNtUVVFRkNabFN3eTlyalI5RElXRW9Sd0VVZzVzM1dNWlRTWmVWYld3R0lDVlRYbXBoSEd2ci1VaXZEeE55aA?oc=5" target="_blank">Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
NEJMgeneral

A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9ndmNsQ2dOWGtvclFmTXE3SEhmR3RRbmVYbXZJN1VXWWVUNTZlcndDYW1vNkdHNDZsRGZ2TjIwZDFyeFlNWUtsUThLVnVCTHJ4Nk14VUxQczU5cEVZRVpSMQ?oc=5" target="_blank">A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study
American Heart Association Journalsgeneral

Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1rUVNlYW5xbHVqVG16YTNMUl9hc2VnSEVZX3Q1d094Ml8zQkZSSlhJM1VoQjltWnRIMlNxVUxVNmhybHhpb3FFVk12dFFsWThLZ2hDZzFMMVhLVlFOdGpoRlpWc1FjbkY1SUE?oc=5" target="_blank">Prasugrel Intermediate Metabolite Modulates Platelet Inhibition by Negatively Interfering With an Active Metabolite: An Ex Vivo, In Vitro, and In Silico Study</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
NEJMgeneral

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE80ZndkVkdXTXFEWE5zalFTNzNSSmxxeHpaQTd4cEZDVkhhSmlDZExqVGs5cHBlSnV3VW5iTWU5UGk3WEZGX0VrRFR4NUFQX2NkaENveENOYkJxUllKUmpidA?oc=5" target="_blank">Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study
Naturegeneral

Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzYUhGVWE3b2c2YVhYSGFJMHVrRzhmaVJ1V2NOVy1lQmx6Vk1sbWlrZlFJaW1leE9Sa204alJfWlVHcmE2OWhJUlJIWDQ3Q1pwWk94c3FjWlFfWWo4MVdJ?oc=5" target="_blank">Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?
American Heart Association Journalsgeneral

Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9OYi1OeFZfSGNsRkM1ZHNvUHJERkhFRWx0VkdFOFNQaHJJX3Z2VGNwclVfZU40Y3ZfWVRRb3ZEQmlWOGJKNzljVTJKXzI2RXllbjY5OEM3U05BU2pmdGdlZ3d3eEkxM1lpUUpsRg?oc=5" target="_blank">Role of Ticagrelor in Clopidogrel Nonresponders: Resistance Is Futile?</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery
American Heart Association Journalsgeneral

Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTFB6RXZYd0tSdG92aGtkZVE3RlVhSV9HM1BwQnNhZlpQZ1Y1Zkp5MTRHMXpBNU9sanNwc0RDcmU0bjVRQnlteGkzMk1NekdTMVNVRU9STHV2N3lTNVd2MktTSFhsRmJxYTBUbEpLMmNRZmQ5c0k?oc=5" target="_blank">Management of Antiplatelet Therapy in Patients With Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction | Circulation: Cardiovascular Interventions
American Heart Association Journalsgeneral

Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction | Circulation: Cardiovascular Interventions

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE5BTkJZN0xvX0dkMzVyV2dzZ29aZjV5R19TVTRwLXl3TGhLc001S2hpRTVxN1hMY2VqMFhLYUJKSDFSMU90Z3hCNmg1aThPVENNZUpsTWtHR1VYbmZMdERXNGtVRWplMWVHRWJfSXRKMG5ucWxtVUhV?oc=5" target="_blank">Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction | Circulation: Cardiovascular Interventions</a>  <font color="#6f6f6f">American Heart Association Journals</font>

Read Full StoryMore like this
Prasugrel provides optimal balance of safety and efficacy after PCI, study suggests
Hospital Healthcare Europegeneral

Prasugrel provides optimal balance of safety and efficacy after PCI, study suggests

<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNYVJyTVVjNFgwZHBZMXpSV0ltcVhZUlJ4aWlOY3hkVzdTdlNkcUlscG9zbGRzZTRaN1Nvaks4ZTdJbHZiOHl0VW43MU1DWVJUWHNQa2dRNms5b2NQX2MxZG1fVVZsNkhrZWlGM2NBOWtxdmR1ZkFZYXFfSnRSeHBfWDhJNE5FN2c2QXp1R2JiUnRkMTFRM21iSGpJUjBtNzF0YlJxU1RyWVNYZm4wOWU4Z1lOaWp5VTNranpOYzNlTFd1OU9MSUtJcWNjU19SX3YyejFhdmdWdWE?oc=5" target="_blank">Prasugrel provides optimal balance of safety and efficacy after PCI, study suggests</a>  <font color="#6f6f6f">Hospital Healthcare Europe</font>

Read Full StoryMore like this
FDA Clears Effient, May be Serious Competitor to Plavix
Diagnostic and Interventional Cardiologygeneral

FDA Clears Effient, May be Serious Competitor to Plavix

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOTzNRRlFOR0F5aDQ2T0VSODR3Y0FXN3Q0Slg1RzR2TmpEaWhyNHhvUXprYk9aQkhyaGd2Ml81c2FsMS1IQndGN3FYM1JTa2hIc2oycGxZLUxLT1pxUkNVaElpUmQtVlNKcmxyaExLQVJNenZrRURPLU83WDVCYnlPdDVuS2dsdnFpeWZNVy04VWg3Zw?oc=5" target="_blank">FDA Clears Effient, May be Serious Competitor to Plavix</a>  <font color="#6f6f6f">Diagnostic and Interventional Cardiology</font>

Read Full StoryMore like this
TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS
TCTMD.comgeneral

TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaUFGbTRZb3VfN0dIclhydkxDaEt6c0dZMW9ULWJSOXFadC1GdDdoTFd1VEY1MW1seGZpVllwbk5rQ2RMdTBlSEpSNTVmZXZHVjlxS0FZM1BuN1VfbHpSTEhUQ1BYaW9FRWVSUDAyVGQ2M1R2Z3psQllRT2kxOGpsdkNXSVhMNHJNNG92b2tmQm12U3E1dTRhVGhPel81X0VrYWYwSm1XX2RGSXk3eEFnUmlGM29oTHFwemkw?oc=5" target="_blank">TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
NEJMgeneral

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE5zRFZ0NVFkc2hycF9yU2pHRFl3UEJVRTNVSm93VUJINWlBZFQ2VTJWV3E1cjMxMW1MQlBMLXNJbnV5MmtDTFh5OWtmUm10aTJhUkIxdngwRVF5UHB6cEFHeQ?oc=5" target="_blank">Cytochrome P-450 Polymorphisms and Response to Clopidogrel</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes
JACC Journalsgeneral

Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE15T09VcDdKdTI1eEdyMG5Rai13aHhZWXZ6bmxyakNVUzZ4OWwxYjhGX0hHTXJOWnpQZzhUdXVRSVhPanlsZlZuT21JWl9VWUdTWG5HSXk3eWRLV3dZdHV4WA?oc=5" target="_blank">Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes</a>  <font color="#6f6f6f">JACC Journals</font>

Read Full StoryMore like this
"Prasugrel versus Clopidog" — Live Google News Trends & Headlines